Register today to access recent news and articles.

Hercules Capital

Hercules Capital provides up to US$50m debt finance to...

Alector, Inc. a clinical-stage biotechnology company pioneering immuno-neurology, has announced the conclusion of a debt financing agreement with Hercules Capital, Inc. for up to US$50m. The agreement stipulates a US10m at closing (Alector drew it), an additional US$15m till June...

#Alector#debt finance#Hercules Capital

Our Sponsors
Our Events
View All
To top
BCR Publishing
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.